The FDA still considers the stem cell therapy investigational, and insurance companies typically will not cover the procedures. Contributors to this news report include: Cyndy McGrath ...
scientists have still lacked a reliable and practical way of tracking protein expression at the level of millions of densely packed individual cells in whole, 3D intact tissues such as an entire ...